Human tumor necrosis factor receptor

Details Human tumor necrosis factor receptor Human tumor necrosis factor receptor

2006-08-22

2006-08-22

Pak, Michael (Department: 1646)

Chemistry: molecular biology and microbiology

Micro-organism, tissue cell culture or enzyme using process...

Recombinant dna technique included in method of making a...

C435S320100, C435S325000, C536S023500

Reexamination Certificate

active

07094564

ABSTRACT:
A human TNF receptor and DNA (RNA) encoding such receptor and a procedure for producing such receptor by recombinant techniques is disclosed. Also disclosed are methods for utilizing such receptor for screening for antagonists and agonists to the receptor and for ligands for the receptor. Also disclosed are methods for utilizing such agonists to inhibit the growth of tumors, to stimulate cellular differentiation, to mediate the immune response and anti-viral response, to regulate growth and provide resistance to certain infections. The use of the antagonists as a therapeutic to treat autoimmune diseases, inflammation, septic shock, to inhibit graft-host reactions, and to prevent apoptosis is also disclosed. Also disclosed are diagnostic methods for detecting mutations in the nucleic acid sequence encoding the receptor and for detecting altered levels of the soluble receptor in a sample derived from a host.

REFERENCES:
patent: 5395760 (1995-03-01), Smith et al.
patent: 5464938 (1995-11-01), Smith et al.
patent: 0 585 939 (1994-03-01), None
patent: 0 816 380 (1998-01-01), None
patent: 0 816 380 (1998-01-01), None
patent: WO 91/09045 (1991-06-01), None
patent: WO 94/09137 (1994-04-01), None
patent: WO 94/13808 (1994-06-01), None
patent: WO 96/26217 (1996-08-01), None
George et al. (1988) Macro Molecular Sequencing and Synthesis. (Ed. by D.H. Schlesinger) Alan R. Liss, Inc., New York, pp. 127-149.
Bowie et al. (1990) Science 247:1307-1310.
Lewis et al. (1991) Proc. Natl. Acad. Sci. 88:2830-2834.
Kwon et al. “TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption” FASEB Journal 12(10):845-854 (1998).
Simonet et al. “Osteoprotegerin: A novel secreted protein involved in the regulation of bone density” Cell 89(2):309-319 (1997).
Tsuda et al. “Isolation of a novel cytokine from human fibrobolasts that specifically inhibits osteoclastogenesis” Biochemical and Biophysical Res. Comms. 234(1):137-142 (1997).
European Search Report, Application No. 96 93 5862, dated Jan. 13, 2003.
Kohno, T. et al., “A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor,”Proc. Natl. Acad. Sci. USA 87:8331-8335 (1990).
Schall, T.J. et al., “Molecular Cloning and Expression of a Receptor for Human Tumor Necrosis Factor,”Cell 61:361-370 (1990).
Aruffo, A.A., et al., Database A-Geneseq24 on MASPAR, Accession No. R38859 (1993).
Aslanidis, C., Database EMBL-new3 on MASPAR, Accession No. X75491 (Mar. 1994).
Genexpress, Database EMBL/Genbank/DDBJ on MASPAR, Accession No. L23876 (1993).
Glasgow, E. and Schechter, N., Database EMBL-new3 on MASPAR, Accession No. L23876 (1993).
Hillier, L., et al., Database EST-STS on MASPAR, Accession No. H14106 (Jul. 1995).
Hudson, T., Database EST-STS on MASPAR, Accession No. G11923 (Oct. 1995).
Zauner, W., et al., Database EMBL-new3 on MASPAR, Accession No. X60370, X60371, X60550 (1992).
NCBI Entrez, GenBank Report, Accession No. D62967, from Fujiwara, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report, Accession No. D63118, from Fujiwara, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report, Accession No. D63125, from Fujiwara, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report, Accession No. D63126, from Fujiwara, T. et al. (Aug. 1995).
NCBI Entrez, GenBank Report, Accession No. AA296905, from Adams, M.D. et al. (Sep. 1995).
NCBI Entrez, GenBank Report, Accession No. AA296908, from Adams, M.D. et al. (Sep. 1995).
NCBI Entrez, GenBank Report, Accession No. 298429, from Adams, M.D. et al. (Sep. 1995).
NCBI Entrez, GenBank Report, Accession No. H88769, from Hillier, L. et al. (Nov. 1995).
NCBI Entrez, GenBank Report, Accession No. C02463, from Okubo, K. et al. (Jul. 1996).
NCBI Entrez, GenBank Report, Accession No. AA037313, from Hillier, L. et al. (Nov. 1996).
NCBI Entrez, GenBank Report, Accession No. AA195113, from Hillier, L. et al. (May 1997).
NCBI Entrez, GenBank Report, Accession No. AA233719, from Hillier, L. et al. (Aug. 1997).
NCBI Entrez, GenBank Report, Accession No. AA706996, from Hillier, L. et al. (Dec. 1997).
NCBI Entrez, GenBank Report, Accession No. AA599841, from Jia, L. et al. (Mar. 1998).
Aggarwal, B. B. and K. Natarajan, “Tumor necrosis factors: Developments during the last decade,”Eur. Cytokine Netw. 7(2):93-124 (Apr.-Jun. 1996).
Camerini, D. et al., “The T Cell Activation Antigen CD27 Is a Member of the Nerve Growth Factor/Tumor Necrosis Factor Receptor Gene Family,”J. Immunol. 147(9):3165-3169 (1991).
Dürkop, H. et al., “Molecular Cloning and Expression of a New Member of the Nerve Growth Factor Receptor Family That Is Characteristic for Hodgkin's Disease,”Cell 68:421-427 (1992).
Engelmann, H. et al., “Two Tumor Necrosis Factor-binding Proteins Purified from Human Urine. Evidence for Immunological Cross-reactivity with Cell Surface Tumor Necrosis Factor Receptors,”J. Biol. Chem. 265(3):1531-1536 (1990).
Himmler, A. et al., “Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein,”DNA and Cell Biol. 9(10):705-715 (1990).
Hohmann, H.-P. et al., “Two Different Cell Types Have Different Major Receptors for Human Tumor Necrosis Factor (TNFα)”J. Biol. Chem. 264(25):14927-14934 (1989).
Hsu, K. C. and M. V. Chao, “Differential Expression and Ligand Binding Properties of Tumor Necrosis Factor Receptor Chimeric Mutants,”J. Biol. Chem. 268(22):16430-16436 (1993).
Itoh, N. et al., “The Polypeptide Encoded by the cDNA for Human Cell Surface Antigen Fas Can Mediate Apoptosis,”Cell 66:233-243 (1991).
Johnson, D. et al., “Expression and Structure of the Human NGF Receptor,”Cell 47:545-554 (1986).
Loetscher, H. et al., “Molecular Cloning and Expression of the Human 55 kd Tumor Necrosis Factor Receptor,”Cell 61:351-359 (1990).
Mallett, S. et al., “Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes—a molecule related to nerve growth factor receptor,”EMBO J. 9(4):1063-1068 (1990).
Nophar, Y. et al., “Soluble forms of tumor necrosis factor receptors (TNF-Rs). The cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble form of the receptor,”EMBO J. 9(10):3269-3278 (1990).
Pfeffer, K. et al., “Mice Deficient for the 55 kd Tumor Necrosis Factor Receptor Are Resistant to Endotoxic Shock, yet Succumb to L. monocytogenes Infection,”Cell 73:457-467 (1993).
Piguet, P. F. et al., “Evolution of collagen arthritis in mice is arrested by treatment with anti-tumour necrosis factor (TNF) antibody or a recombinant soluble TNF receptor,”Immunol. 77:510-514 (1992).
Radeke, M. J. et al., “Gene transfer and molecular cloning of the rat nerve growth factor receptor,”Nature 325:593-597 (1987).
Smith, C. A. et al., “T2 Open Reading Frame from the Shope Fibroma Virus Encodes a Soluble Form of the TNF Receptor,”Biochem. Biophys. Res. Comm. 176(1):335-342 (1991).
Stamenkovic, I. et al., “A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas,”EMBO J. 8(5):1403-1410 (1989).
Van Ostade, X. et al., “Human tumor necrosis factor mutants with preferential binding to and activity on either the R55 or R75 receptor,”Eur. J. Biochem. 220(3):771-779 (Mar. 1994).
Chinnaiyan, A.M. et al., “Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95,”Science 274:990-992 (1996).
Feinstein, E. et al., “The death domain: a module shared by proteins with diverse cellular functions,”TIBS 20:342-344 (Sep. 1995).
Muzio, M. et al., “FLICE, A Novel FADD-Homologous ICE/CED-3-like Protease, Is Recruited to th

Affiliated with

Also associated with

Rating

Human tumor necrosis factor receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human tumor necrosis factor receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human tumor necrosis factor receptor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3662298